Pharma-Biotech Alliance ManagementCritical Success Factors

 

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

This research service provides an overview of the pharma-biotech industry in terms of critical success factors and alliance management.

Table of Contents

Pharma-Biotech Alliance Management—Critical Success Factors, Executive SummaryOverviewSummary of Pharma-Biotech Alliance Management - Critical Success FactorsPharma-Biotech Alliance Management—Critical Success Factors, Exchange RatesExchange RatesCurrency Exchange RatesPharma-Biotech Alliance Management—Critical Success Factors, Research Scope and MethodologyScope and MethodologyResearch MethodologyPharma-Biotech Alliance Management—Critical Success Factors, Introduction and SegmentationIntroductionBackgroundSegmentationPharma-Biotech Alliance Management—Critical Success Factors, Pharmaceutical Industry OverviewOverviewOverview of the Pharmaceutical IndustryIdentification of the Challenges Facing Pharmaceutical CompaniesPharma-Biotech Alliance Management—Critical Success Factors, Biotechnology Industry OverviewOverviewOverview of the Biotechnology IndustryIdentification of the Challenges Facing Biotechnology CompaniesPharma-Biotech Alliance Management—Critical Success Factors, Key Challenges in Alliance ManagementChallengesChallengesPharma-Biotech Alliance Management—Critical Success Factors, Key Drivers in Alliance ManagementMarket DriversMarket DriversPharma-Biotech Alliance Management—Critical Success Factors, Pharma - Biotech AlliancesAlliancesIntroductionOverview and Key TrendsKey Pharma-Biotech AlliancesCase Study - NovartisPharma-Biotech Alliance Management—Critical Success Factors, Biotech - Biotech AlliancesAlliancesIntroductionOverview and Key TrendsKey Biotech-Biotech AlliancesCase Study - SeronoPharma-Biotech Alliance Management—Critical Success Factors, Critical Success FactorsSuccess FactorsSuccess Factors Pharma-Biotech Alliance Management—Critical Success Factors, Strategic Recommendations for Alliance ManagementRecommendationsRecommendationsEmerging / Small Biotech CompaniesLarger Biotech / Biopharmaceutical CompaniesLarge Pharma CompaniesSummaryPharma-Biotech Alliance Management—Critical Success Factors, Frost & Sullivan AwardsFrost & Sullivan Awards for the European Pharma and Biotech Industry2006 Frost & Sullivan AwardsEntrepreneurial Company AwardTechnology Innovation AwardCompetitive Strategy Leadership AwardPharma-Biotech Alliance Management—Critical Success Factors, Key Industry ParticipantsIndustry ParticipantsMajor ParticipantsPharma-Biotech Alliance Management—Critical Success Factors, Decision Support DatabasesBiotechNumber of Biotech CompaniesNumber of Employees in Biotech CompaniesEPO Biotech PatentGovernment R&D Investment in BiotechnologyPercent Government Biotech R & D InvestmentPrivate Investment in BiotechnologyPer cent Private Investment in BiotechnologyPharmaceutical R&DPharmaceutical R&D ExpenditurePercent Pharmaceutical R&D Expenditure




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.